Skip to main content
Log in

Introductory remarks

  • Round Table Discussion
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rubin, R. H., Shapiro, E. D., Andriole, V. T., Davis, R. J., Stamm, W. E. General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin. Infect. Dis. 15 (Suppl. 1) (1992) S 216-S 227.

    Google Scholar 

  2. Rubin, R. H., Shapiro, E. D., Andriole, V. T., Davis, R. J., Stamm, W. E. with modifications by a European Working Party: General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection. The European Society of Clinical Microbiology and Infections Diseases, 1993.

  3. Ohkoshi, M., Kawada, Y. (eds): Clinical evaluation of drug efficacy in UTI. Proceedings of the 1st International Symposium, 27–28 October 1989, Tokyo, Japan. Excerpta Medica, Amsterdam, New York, Oxford 1990, p. 146, p. 230.

    Google Scholar 

  4. Ohkoshi, M., Naber, K. G., Adam, D., Kawada, Y., Kumamoto, Y., Kumazawa, J., Neu, H. C., Ronald, A. R., Schaeffer, A. J., Stamm, W. E.: International consensus discussion on clinical evaluation of drug efficacy in urinary tract infection. Proceedings of the 2nd International Symposium on Clinical Evaluation of Drug Efficacy in Urinary Tract Infection, 28–29 June 1991, Berlin, Germany. Infection Suppl. 3 (1992).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naber, K.G. Introductory remarks. Infection 22 (Suppl 1), S35 (1994). https://doi.org/10.1007/BF01716038

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01716038

Keywords

Navigation